Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.028

+0.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Czechsinthemail who wrote (18)	8/21/1997 10:14:00 AM
From: kinkblot	of 179

Baird, I can't answer your question on competitors, but it seems to me that Pharmacopeia's technical edge derives from their molecular tagging system, which is patented. The patent issued October 1996 is U.S. Patent No. 5,565,324 "Complex combinatorial libraries encoded with tags". It appears to be a relatively broad method patent with no restriction on the identifiers except attachment to a solid support. They will have an advantage over others using "pool and synthesis" if their tagging technology gives them a superior method for identifying the active compounds. IBM Patent Server shows abstract, claims, and references: patent.womplex.ibm.com No other patent in their database has referenced this one. If you give any credence to technical analysis, take a look at On Balance Volume for PCOP on daily charts - OBV is making new highs. Also, as of 8/20 close Bollinger Bands are at 15.0 upper, 14.4 middle, 13.9 lower, with relative bandwidth versus four month average of only .36, indicating an increase in volatility is likely soon. Will

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next